Total Ideas
1
Bullish Ideas
0 (0%)
Bearish Ideas
Recent Activity
0
"PBSV: Microcap pharma consulting firm trading at net cash value with 15% dividend yield. Core business can earn $2M/yr (5x = $10M). Signs of recovery with European projects growing to 25% of rev (higher margin). Risks: CEO lacks ownership, customer concentration, tax grant ending 2024. 2x upside potential."
Sentiment